The global blood testing market is experiencing strong growth as healthcare systems increasingly emphasize early disease detection, preventive healthcare, and advanced diagnostic technologies. Blood testing plays a crucial role in modern medicine by enabling healthcare professionals to diagnose diseases, monitor patient health, and guide treatment decisions through accurate laboratory analysis.

The global blood testing market was valued at US$ 104.4 Billion in 2024 and is projected to cross US$ 249.7 Billion by the end of 2035, expanding at a compound annual growth rate (CAGR) of 8.2% from 2025 to 2035. The rising prevalence of chronic diseases, increasing health awareness, expanding diagnostic laboratory networks, and advancements in diagnostic technologies are expected to drive market growth during the forecast period.

Get your sample market research report copy today@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2517

Market Overview

Blood testing is one of the most widely used diagnostic procedures in healthcare. It involves analyzing blood samples to evaluate various health indicators such as glucose levels, cholesterol levels, infection markers, hormone levels, and blood cell counts.

These tests help physicians detect and monitor conditions such as diabetes, cardiovascular diseases, cancer, infectious diseases, anemia, and metabolic disorders. Blood tests are also commonly used in routine health checkups, pregnancy monitoring, and pre-surgical evaluations.

Rising Prevalence of Chronic Diseases

One of the primary drivers of the blood testing market is the increasing global burden of chronic diseases. Conditions such as diabetes, cardiovascular disorders, kidney diseases, and cancer require regular blood testing for early detection and ongoing patient monitoring.

According to global health studies, millions of people worldwide are diagnosed with chronic illnesses each year, creating strong demand for diagnostic testing services. Blood tests help healthcare providers detect abnormalities at early stages, allowing timely medical intervention and improved patient outcomes.

Growing Focus on Preventive Healthcare

Healthcare systems across the world are increasingly focusing on preventive healthcare and routine health screening programs. Blood tests are a fundamental component of preventive healthcare because they allow physicians to identify potential health risks before symptoms appear.

Routine blood tests such as complete blood count (CBC), lipid profile tests, liver function tests, and glucose tests help individuals monitor their overall health and detect potential medical conditions at an early stage.

Technological Advancements in Diagnostic Testing

Rapid technological advancements in diagnostic testing technologies are significantly transforming the blood testing industry. Modern laboratories are increasingly adopting automated analyzers, high-throughput diagnostic systems, and digital laboratory management solutions.

Technologies such as molecular diagnostics, next-generation sequencing, and point-of-care blood testing devices are improving diagnostic accuracy and reducing turnaround time for test results.

Increasing Demand for Personalized Medicine

The growing focus on personalized medicine is another factor supporting the expansion of the blood testing market. Personalized medicine uses patient-specific biological data to develop targeted treatment strategies.

Blood testing plays a vital role in identifying genetic markers, biomarkers, and molecular signatures that help physicians design individualized treatment plans for patients. This approach is particularly important in fields such as oncology, immunology, and precision medicine.

Key Developments

• In May 2025, Fujirebio announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its LumipulseG pTau 217/β-Amyloid 1-42 Plasma Ratio in-vitro diagnostic (IVD) test for assessing amyloid pathology in patients being evaluated for Alzheimer’s disease and the other causes of cognitive decline.
• In December 2024, BD (Becton, Dickinson and Company), and Babson Diagnostics announced an expansion of fingertip blood collection and testing technologies for use by U.S. health systems and other large provider networks in settings like urgent cares, doctor offices and other ambulatory care settings
• In July 2024, Guardant Health, Inc. announced that it had approved the company’s Shield blood test for colorectal cancer (CRC) screening in adults aged 45 and above who are at average risk for the disease. It is the first blood test to be approved by the U.S. FDA as a primary screening option for CRC, meaning healthcare providers can offer Shield in a manner similar to all the other non-invasive methods recommended in screening guidelines.

Discuss Implications for Your Industry Request Sample Research Report PDF@ https://www.transparencymarketresearch.com/blood-testing-market.html

Regional Analysis

North America

North America holds a significant share of the global blood testing market due to its advanced healthcare infrastructure, high healthcare spending, and widespread adoption of advanced diagnostic technologies. The United States dominates the regional market with a large number of diagnostic laboratories, hospitals, and research institutions.

Europe

Europe is another major market for blood testing services, supported by well-established healthcare systems and increasing focus on disease prevention. Countries such as Germany, the United Kingdom, and France have strong laboratory networks and advanced medical research facilities.

Asia Pacific

Asia Pacific is expected to witness the fastest growth during the forecast period. Rapid population growth, improving healthcare infrastructure, and increasing healthcare awareness in countries such as China, India, Japan, and South Korea are fueling demand for diagnostic testing services.

Latin America and Middle East & Africa

The blood testing market in Latin America and the Middle East & Africa is gradually expanding due to improving healthcare facilities and increasing awareness about early disease detection. Rising investments in diagnostic laboratories and hospital infrastructure are expected to support market growth in these regions.

Leading Companies in the Blood Testing Market

The global blood testing market includes several major diagnostic companies and laboratory service providers focusing on technological innovation and expanding testing capabilities.

Key companies operating in the market include:

• Abbott
• F. Hoffmann-La Roche AG
• Thermo Fisher Scientific Inc.
• Bio‑Rad Laboratories
• BIOMÉRIEUX
• Quest Diagnostics
• Grifols, S.A
• Sysmex Corporation
• Guardant Health
• GRAIL, Inc.
• Everlywell
• Freenome Holdings, Inc
• Hologic, Inc.
• Trinity Biotech
• Other Prominent Players

These companies are investing heavily in research and development to introduce advanced diagnostic technologies and expand global laboratory networks.

Market Challenges

Despite strong growth prospects, the blood testing market faces certain challenges. High costs associated with advanced diagnostic technologies may limit access in some developing regions.

Additionally, regulatory requirements and quality standards for diagnostic testing laboratories can create barriers for new market entrants. However, ongoing technological advancements and expanding healthcare access are expected to address these challenges over time.

Future Outlook

The future of the blood testing market looks promising as healthcare systems increasingly emphasize early diagnosis, preventive care, and personalized medicine. Technological innovations, growing diagnostic awareness, and expanding healthcare infrastructure will continue to drive market growth.

With the global market expected to cross US$ 249.7 Billion by 2035, blood testing will remain one of the most essential diagnostic tools in modern healthcare systems worldwide.

To buy this comprehensive market research report, click here to inquire@ https://www.transparencymarketresearch.com/checkout.php?rep_id=2517&ltype=S

Frequently Asked Questions (FAQs)

Q1. What is the projected size of the global blood testing market by 2035?
The market is expected to exceed US$ 249.7 Billion by the end of 2035.

Q2. What is the expected CAGR of the blood testing market?
The market is projected to grow at a CAGR of 8.2% from 2025 to 2035.

Q3. What factors are driving the growth of the blood testing market?
Key drivers include rising prevalence of chronic diseases, increasing demand for preventive healthcare, technological advancements in diagnostics, and growing personalized medicine applications.

Q4. Which region dominates the blood testing market?
North America holds a significant share due to advanced healthcare infrastructure and strong diagnostic laboratory networks.

Q5. Which companies are major players in the blood testing market?
Major companies include Quest Diagnostics, LabCorp, Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific.

More Trending Research Reports-

➤ Opioid Induced Constipation Treatment Market – https://www.transparencymarketresearch.com/opioidinduced-constipation-treatment-market.html
➤ Bacterial Conjunctivitis Drugs Market – https://www.transparencymarketresearch.com/bacterial-conjunctivitis-drugs-market.html
➤ Automotive Tire Market – https://www.transparencymarketresearch.com/automotive-tire-market.html
➤ Vehicle Predictive Maintenance Market- https://www.transparencymarketresearch.com/vehicle-predictive-maintenance-market.html

About Us Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

Contact Us:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453